ADMA Biologics, Inc. (ADMA)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
As of 11:53AM EDT. Market open.
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 1.52B |
| Enterprise Value | 1.61B |
| Trailing P/E | N/A |
| Forward P/E | 22.57 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 5.67 |
| Price/Book (mrq) | 11.21 |
| Enterprise Value/Revenue | 6.22 |
| Enterprise Value/EBITDA | 313.64 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 0.43 |
| 52-Week Change 3 | 98.18% |
| S&P500 52-Week Change 3 | 25.01% |
| 52 Week High 3 | 6.76 |
| 52 Week Low 3 | 3.06 |
| 50-Day Moving Average 3 | 5.97 |
| 200-Day Moving Average 3 | 4.50 |
Share Statistics
| Avg Vol (3 month) 3 | 2.53M |
| Avg Vol (10 day) 3 | 2.21M |
| Shares Outstanding 5 | 231.77M |
| Implied Shares Outstanding 6 | 231.77M |
| Float 8 | 223.68M |
| % Held by Insiders 1 | 2.59% |
| % Held by Institutions 1 | 76.92% |
| Shares Short (Mar 28, 2024) 4 | 7.29M |
| Short Ratio (Mar 28, 2024) 4 | 2.09 |
| Short % of Float (Mar 28, 2024) 4 | 3.35% |
| Short % of Shares Outstanding (Mar 28, 2024) 4 | 3.20% |
| Shares Short (prior month Feb 29, 2024) 4 | 6.72M |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | N/A |
| Last Split Date 3 | N/A |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 31, 2023 |
| Most Recent Quarter (mrq) | Dec 31, 2023 |
Profitability
| Profit Margin | -10.94% |
| Operating Margin (ttm) | 19.26% |
Management Effectiveness
| Return on Assets (ttm) | 4.51% |
| Return on Equity (ttm) | -19.67% |
Income Statement
| Revenue (ttm) | 258.22M |
| Revenue Per Share (ttm) | 1.15 |
| Quarterly Revenue Growth (yoy) | 47.90% |
| Gross Profit (ttm) | N/A |
| EBITDA | 32.76M |
| Net Income Avi to Common (ttm) | -28.24M |
| Diluted EPS (ttm) | -0.13 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 51.35M |
| Total Cash Per Share (mrq) | 0.22 |
| Total Debt (mrq) | 141.42M |
| Total Debt/Equity (mrq) | 104.59% |
| Current Ratio (mrq) | 5.16 |
| Book Value Per Share (mrq) | 0.60 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 8.8M |
| Levered Free Cash Flow (ttm) | 378.12k |
© 2024 Yahoo. All rights reserved.